Stock News

Investor Alert: Class Action Lawsuit Against Walgreens Boots Alliance Background Recently, The Schall Law Firm, a national shareholder rights litigation firm, issued a reminder to investors regarding a class action lawsuit against Walgreens Boots Alliance, Inc. (“Walgreens” or “the Company”). The lawsuit alleges violations of 10(b) and 20(a) of the Securities Exchange Act of 1934…

CorMedix Inc. Enters into Multi-Year Commercial Supply Contract for DefenCath® BERKELEY HEIGHTS, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a leading biopharmaceutical company dedicated to developing therapeutic products for life-threatening diseases and conditions, has recently announced a significant achievement in the form of a multi-year commercial supply contract with a global…

Welcome to Zacks Blog Zacks Rank System: A Proven Method for Stock Selection Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. We believe that by focusing on these key factors, we can identify stocks that have the potential to outperform…

Welcome to the Investor’s Lounge! Feeling the Sting of a Bad Investment? Hey there, fellow investor! If you’re reading this, chances are you may have experienced a bit of a setback with your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment. It happens to the best of us – the market can be a tricky beast to…

Apple to Use Arm Holdings’ AI Chip Technology in iPhone 16 Shares of Arm Holdings Surge After Report Shares of chipmaker Arm Holdings (NASDAQ:ARM) are up 3.3% to trade at $121.15 at last check, after the Financial Times reported the company’s artificial intelligence (AI) chip technology will be used in Apple’s (AAPL) iPhone 16 that…

Atlassian: A Bright Future Ahead Investing in Innovation Despite short-term volatility and lower-than-expected revenue and margin guidance for FY25, I maintain a “buy” rating on Atlassian with a $171 price target. The company’s commitment to robust product innovation and enterprise penetration, particularly with AI-led solutions, is a key driver of its long-term growth potential and…

Applied Digital (NASDAQ: APLD) Soars 20% on $160 Million Strategic Financing Deal The Game-Changing Investment Applied Digital (NASDAQ: APLD) saw its stock soar nearly 20% last week after announcing a significant $160 million strategic financing deal through a private placement, priced at market value. This investment came from institutional and accredited investors, including tech giant…

Medical Advances in Dermatology: The Impact of New Treatments The Changing Landscape of Advanced Dermatology Treatments According to the latest research from Spherix Global Insights, there has been a noticeable shift in the reported use of advanced dermatology treatments. While Sanofi/Regeneron’s Dupixent was once a dominant player in the market, its popularity has declined with…